Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser

Anadi Khatri,1 Eli Pradhan,2 Sweta Singh,1 Roshija Rijal,1 Bal Kumar Khatri,3 Gyanendra Lamichhane,1 Muna Kharel4 1Department of Retina, Lumbini Eye Institute, Lumbini, Nepal; 2Department of Retina, Tilganga Institute of Ophthalmology, Kathmandu, Nepal; 3Department of Ophthalmology, Birat Eye Hospi...

Full description

Bibliographic Details
Main Authors: Khatri A, Pradhan E, Singh S, Rijal R, Khatri BK, Lamichhane G, Kharel M
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Clinical Ophthalmology
Subjects:
PED
532
Online Access:https://www.dovepress.com/going-green-ndash-treatment-outcome-and-safety-profile-of-chronic-cent-peer-reviewed-article-OPTH
id doaj-8e3f7274a1ea42c8b7721b9f33c66d93
record_format Article
spelling doaj-8e3f7274a1ea42c8b7721b9f33c66d932020-11-25T00:33:41ZengDove Medical PressClinical Ophthalmology1177-54832018-10-01Volume 121963197141164Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laserKhatri APradhan ESingh SRijal RKhatri BKLamichhane GKharel MAnadi Khatri,1 Eli Pradhan,2 Sweta Singh,1 Roshija Rijal,1 Bal Kumar Khatri,3 Gyanendra Lamichhane,1 Muna Kharel4 1Department of Retina, Lumbini Eye Institute, Lumbini, Nepal; 2Department of Retina, Tilganga Institute of Ophthalmology, Kathmandu, Nepal; 3Department of Ophthalmology, Birat Eye Hospital, Biratnagar, Nepal; 4Department of Ophthalmology, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal Aim: Subthreshold lasers have gained popularity in the treatment of chorioretinopathy central serous chorioretinopathy (CSCR) and yellow (577 nm) lasers have completely revolutionized the treatment. However, there is very little literature regarding the use of a more common and conventional – green (532 nm) subthreshold laser for the treatment of chronic CSCR. We report the use of green (532 nm) laser for the treatment of chronic CSCR and its outcome.Methods: Eyes with nonresolving CSCR were treated with green subthreshold laser and evaluated at the end of 5 months. Visual acuity, central macular thickness (CMT), and macular volume (MV) at baseline and at 5 months following treatment were evaluated.Results: Thirteen eyes with chronic CSCR were treated with green laser in SP-Mode™. The mean duration of CSCR was 7.64±3.77 months at the time of treatment. The median age of the patients was 41 (35–57) years. The baseline mean best-corrected visual acuity (BCVA) was 0.96 logMAR ± 0.17, with mean baseline CMT of 503.8 µm ± 181.9 and MV of 12.8 mm3 ± 3.81. The mean CMT at 5 months was 211 µm ± 31.7 and mean MV was 9.65 mm3 ± 0.60, correlating to a mean decrease of 292 µm ± 79 in CMT and mean decrease of 3.18 mm3 ± 1.87 in the MV from baseline (P<0.05). The mean BCVA after treatment was 0.18 logMAR±0.09 (P<0.05). Two cases of CSCR with pigment epithelial detachment (PED) also had complete resolution of both at 5 months.Conclusion: Subthreshold green laser (532 nm) is a safe and effective modality for the treatment of chronic CSCR with very good and stable outcomes. It may also be beneficial in the treatment of PEDs. Keywords: CSCR, green laser, subthreshold, 532 nm, PEDhttps://www.dovepress.com/going-green-ndash-treatment-outcome-and-safety-profile-of-chronic-cent-peer-reviewed-article-OPTHcscrchronic cscrgreenlasergreen subthresholdPED532
collection DOAJ
language English
format Article
sources DOAJ
author Khatri A
Pradhan E
Singh S
Rijal R
Khatri BK
Lamichhane G
Kharel M
spellingShingle Khatri A
Pradhan E
Singh S
Rijal R
Khatri BK
Lamichhane G
Kharel M
Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
Clinical Ophthalmology
cscr
chronic cscr
green
laser
green subthreshold
PED
532
author_facet Khatri A
Pradhan E
Singh S
Rijal R
Khatri BK
Lamichhane G
Kharel M
author_sort Khatri A
title Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
title_short Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
title_full Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
title_fullStr Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
title_full_unstemmed Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
title_sort going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2018-10-01
description Anadi Khatri,1 Eli Pradhan,2 Sweta Singh,1 Roshija Rijal,1 Bal Kumar Khatri,3 Gyanendra Lamichhane,1 Muna Kharel4 1Department of Retina, Lumbini Eye Institute, Lumbini, Nepal; 2Department of Retina, Tilganga Institute of Ophthalmology, Kathmandu, Nepal; 3Department of Ophthalmology, Birat Eye Hospital, Biratnagar, Nepal; 4Department of Ophthalmology, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal Aim: Subthreshold lasers have gained popularity in the treatment of chorioretinopathy central serous chorioretinopathy (CSCR) and yellow (577 nm) lasers have completely revolutionized the treatment. However, there is very little literature regarding the use of a more common and conventional – green (532 nm) subthreshold laser for the treatment of chronic CSCR. We report the use of green (532 nm) laser for the treatment of chronic CSCR and its outcome.Methods: Eyes with nonresolving CSCR were treated with green subthreshold laser and evaluated at the end of 5 months. Visual acuity, central macular thickness (CMT), and macular volume (MV) at baseline and at 5 months following treatment were evaluated.Results: Thirteen eyes with chronic CSCR were treated with green laser in SP-Mode™. The mean duration of CSCR was 7.64±3.77 months at the time of treatment. The median age of the patients was 41 (35–57) years. The baseline mean best-corrected visual acuity (BCVA) was 0.96 logMAR ± 0.17, with mean baseline CMT of 503.8 µm ± 181.9 and MV of 12.8 mm3 ± 3.81. The mean CMT at 5 months was 211 µm ± 31.7 and mean MV was 9.65 mm3 ± 0.60, correlating to a mean decrease of 292 µm ± 79 in CMT and mean decrease of 3.18 mm3 ± 1.87 in the MV from baseline (P<0.05). The mean BCVA after treatment was 0.18 logMAR±0.09 (P<0.05). Two cases of CSCR with pigment epithelial detachment (PED) also had complete resolution of both at 5 months.Conclusion: Subthreshold green laser (532 nm) is a safe and effective modality for the treatment of chronic CSCR with very good and stable outcomes. It may also be beneficial in the treatment of PEDs. Keywords: CSCR, green laser, subthreshold, 532 nm, PED
topic cscr
chronic cscr
green
laser
green subthreshold
PED
532
url https://www.dovepress.com/going-green-ndash-treatment-outcome-and-safety-profile-of-chronic-cent-peer-reviewed-article-OPTH
work_keys_str_mv AT khatria goinggreenndashtreatmentoutcomeandsafetyprofileofchroniccentralserouschorioretinopathytreatedwithsubthresholdgreenlaser
AT pradhane goinggreenndashtreatmentoutcomeandsafetyprofileofchroniccentralserouschorioretinopathytreatedwithsubthresholdgreenlaser
AT singhs goinggreenndashtreatmentoutcomeandsafetyprofileofchroniccentralserouschorioretinopathytreatedwithsubthresholdgreenlaser
AT rijalr goinggreenndashtreatmentoutcomeandsafetyprofileofchroniccentralserouschorioretinopathytreatedwithsubthresholdgreenlaser
AT khatribk goinggreenndashtreatmentoutcomeandsafetyprofileofchroniccentralserouschorioretinopathytreatedwithsubthresholdgreenlaser
AT lamichhaneg goinggreenndashtreatmentoutcomeandsafetyprofileofchroniccentralserouschorioretinopathytreatedwithsubthresholdgreenlaser
AT kharelm goinggreenndashtreatmentoutcomeandsafetyprofileofchroniccentralserouschorioretinopathytreatedwithsubthresholdgreenlaser
_version_ 1725315479798546432